MedPath

Efficacy Study of Transcranial Magnetic Stimulation for Treatment of Obsessive-Compulsive Disorder

Phase 2
Completed
Conditions
Obsessive Compulsive Disorder
Registration Number
NCT01540305
Lead Sponsor
University of Brasilia
Brief Summary

This study aimed at verifying whether sessions of repetitive transcranial magnetic stimulation over a certain brain area (the supplementary motor area) could be useful in the relief of Obsessive-Compulsive Disorder symptoms.

Detailed Description

Patients were randomly administered either real (n = 12) or sham (n = 10) rTMS, once a day, 5 days a week, for 2 weeks. Randomization was performed according to a computer-generated schedule. Subjects and scale-rater physician were blind to treatment status of individuals. Only the rTMS administrator was aware of group allocations. Treatment response was assessed by self-and clinician-rated scales before treatment, immediately after treatment and 3 months thereafter, with the same examiner following a subject throughout the study. All patients included in the study had failed adequate pharmacological treatment for at least 2 antiobsessional drugs. Their prescription drugs were continued without change in dosage regimens throughout the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria
  • age 18 to 60 years
  • diagnosis of obsessive-compulsive disorder (OCD) according to DSM-IV-TR criteria and having OCD of at least moderate severity (YBOCS score of 16 or above).
Exclusion Criteria
  • subjects with comorbid psychiatric disorders (except depression - HAM-D ) or history of drug abuse
  • significant head injury, or of any neurosurgical procedure
  • pregnant women
  • patients with metal implants or illnesses that prevent attendance to sessions
  • patients with a history of seizure or bearing pacemakers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Changes in Y-BOCS scale scores relative to baselineassessments were at baseline, at 2 weeks and at 3 months

Y-BOCS: Yale-Brown Obsessive-Compulsive Scale

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Laboratory of Neurosciences and Behavior, Biology Institute, University of Brasília

🇧🇷

Brasília, DF, Brazil

Laboratory of Neurosciences and Behavior, Biology Institute, University of Brasília
🇧🇷Brasília, DF, Brazil
© Copyright 2025. All Rights Reserved by MedPath